Skip to main content
. 2020 Sep 17;10:15244. doi: 10.1038/s41598-020-72179-0

Figure 1.

Figure 1

TAM-mediated induction of YFP reporter. (A) Representative scatter plots of the gating strategy to identify Cre activity by the expression of the YFP reporter among CD45+ cells on day 5 after initiation of treatment with 3 mg TAM PO for 5 days. (B) Testing of TAM dosage (2.4 mg and 1.2 mg) given IP and PO every other day for 5 days (n = 3–5/group). Data are presented as mean with standard error of the mean (SEM). Mixed model ANOVA test with repetitive measures was carried out to identify significant differences when testing different concentrations and delivery methods. *p ≤ 0.05.